Showing codes 16571-833-16 Pryidostigmine Bromide — 16571-865-01 Potassium Citrate

16571-833-16 - Pryidostigmine Bromide
Firm: Rising Pharma Holdings, Inc.
Package Description: 473 mL in 1 BOTTLE, PLASTIC (16571-833-16)
Usage type: ORAL
HTML  TXT

16571-834-01 - Amantadine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 CAPSULE in 1 BOTTLE (16571-834-01)
Usage type: ORAL
HTML  TXT

16571-834-50 - Amantadine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 CAPSULE in 1 BOTTLE (16571-834-50)
Usage type: ORAL
HTML  TXT

16571-835-01 - Azathioprine
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 TABLET in 1 BOTTLE (16571-835-01)
Usage type: ORAL
HTML  TXT

16571-835-10 - Azathioprine
Firm: Rising Pharma Holdings, Inc.
Package Description: 1000 TABLET in 1 BOTTLE (16571-835-10)
Usage type: ORAL
HTML  TXT

16571-835-50 - Azathioprine
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 TABLET in 1 BOTTLE (16571-835-50)
Usage type: ORAL
HTML  TXT

16571-842-01 - Potassium Chloride Extended Release
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-842-01)
Usage type: ORAL
HTML  TXT

16571-842-50 - Potassium Chloride Extended Release
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-842-50)
Usage type: ORAL
HTML  TXT

16571-843-01 - Potassium Chloride Extended Release
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-01)
Usage type: ORAL
HTML  TXT

16571-843-50 - Potassium Chloride Extended Release
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-50)
Usage type: ORAL
HTML  TXT

16571-852-03 - Memantine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-852-03)
Usage type: ORAL
HTML  TXT

16571-853-03 - Memantine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-853-03)
Usage type: ORAL
HTML  TXT

16571-853-09 - Memantine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-853-09)
Usage type: ORAL
HTML  TXT

16571-854-03 - Memantine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-854-03)
Usage type: ORAL
HTML  TXT

16571-855-03 - Memantine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-855-03)
Usage type: ORAL
HTML  TXT

16571-855-09 - Memantine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-855-09)
Usage type: ORAL
HTML  TXT

16571-856-01 - Pentoxifylline
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01)
Usage type: ORAL
HTML  TXT

16571-856-50 - Pentoxifylline
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50)
Usage type: ORAL
HTML  TXT

16571-856-90 - Pentoxifylline
Firm: Rising Pharma Holdings, Inc.
Package Description: 1 BLISTER PACK in 1 CARTON (16571-856-90) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Usage type: ORAL
HTML  TXT

16571-861-25 - Olopatadine Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 1 CONTAINER in 1 CARTON (16571-861-25) / 2.5 mL in 1 CONTAINER
Usage type: OPHTHALMIC
HTML  TXT

16571-862-03 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-03)
Usage type: ORAL
HTML  TXT

16571-862-09 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-09)
Usage type: ORAL
HTML  TXT

16571-862-10 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-10)
Usage type: ORAL
HTML  TXT

16571-862-12 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-12)
Usage type: ORAL
HTML  TXT

16571-862-50 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-50)
Usage type: ORAL
HTML  TXT

16571-863-03 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-03)
Usage type: ORAL
HTML  TXT

16571-863-09 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-09)
Usage type: ORAL
HTML  TXT

16571-863-10 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-10)
Usage type: ORAL
HTML  TXT

16571-863-50 - Bupropion Hydrochloride
Firm: Rising Pharma Holdings, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-50)
Usage type: ORAL
HTML  TXT

16571-864-01 - Potassium Citrate
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-864-01)
Usage type: ORAL
HTML  TXT

16571-865-01 - Potassium Citrate
Firm: Rising Pharma Holdings, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-865-01)
Usage type: ORAL
HTML  TXT